The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes following long-term response to immune checkpoint inhibitors in patients with advanced melanoma.
 
Eleanor Handel
No Relationships to Disclose
 
Janet McKeown
No Relationships to Disclose
 
Joe Wei
No Relationships to Disclose
 
Roma Kankaria
No Relationships to Disclose
 
Hannah Burnette
No Relationships to Disclose
 
Aleigha Lawless
No Relationships to Disclose
 
Juliane Czapla
No Relationships to Disclose
 
Lea Jessica Albrecht
Honoraria - BMS; Novartis; Sun Pharma
Travel, Accommodations, Expenses - Sanofi; Sun Pharma; Takeda
 
Joanna Mangana
Honoraria - BMS; MSD
Consulting or Advisory Role - BMS; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - BMS (Inst); MSD (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Pierre Fabre
 
Jolien Isabel Kessels
Honoraria - Bristol-Myers Squibb Belgium
Consulting or Advisory Role - La Roche Posay
Travel, Accommodations, Expenses - Novartis; Sanofi/Regeneron
 
Clara Allayous
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Christina Ann Boatwright
Employment - NYU Langone Medical Center
 
Margaret Ottaviano
Honoraria - Novartis
Speakers' Bureau - Bristol-Myers Squibb/Celgene; MSD; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis/Pfizer; Pierre Fabre; Sun Pharma
 
Anna Malgorzata Czarnecka
Honoraria - Bristol-Myers Squibb; Merck; MSD Oncology; Novartis; Nutricia; Pierre Fabre; Regeneron
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Pierre Fabre
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Blueprint Medicines; Bristol-Myers Squibb; MSD; Novartis; Philogen; Pierre Fabre
Speakers' Bureau - Novartis; Pfizer; Pierre Fabre
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pierre Fabre (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Orphan Europe; Pierre Fabre
 
Serigne N Lo
No Relationships to Disclose
 
Georgina V. Long
Honoraria - BMS; Pierre Fabre
Consulting or Advisory Role - Agenus; Amgen; Array BioPharma; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; Evaxion Biotech; Hexal; Highlight Therapeutics; Immunocore Ireland Limited; Innovent Biologics; IO Biotech; Merck Sharp & Dohme; Novartis; OncoSec; PHMR; Pierre Fabre; Regeneron
 
Alexander M. Menzies
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; QBiotics; Roche
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; IDEAYA Biosciences; Merck Serono; Moderna Therapeutics; MSD; Nektar; Novartis; OncoSec; Pierre Fabre; QBiotics; Regeneron; Roche; Sanofi